IDD-3

Ask the supplier | View on supplier's website

IDD-3 is a therapeutic specific immunostimulant developed by IDM Pharma in partnership with sanofi-aventis. It consists of mature dendritic cells loaded with lysates from melanoma tumor cell lines. It includes Dendritophages that are dendritic cells, a type of specialized immune cells derived from the patient's own white blood cells.

Supplier	Creative Biomart
Product #	VAC-0327
Pricing	0.5ml : USD $1998

Feedback